![Jeff Jonas](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeff Jonas
Directeur/Membre du Conseil chez
COMPASS PATHWAYS PLC
Fortune : - $ au 31/05/2026
Profil
Jeffrey M. Jonas a fondé AVAX Technologies, Inc. et Evogen, Inc. Il est directeur et chef de l'innovation chez SAGE Therapeutics, Inc. Le Dr Jonas siège également au conseil d'administration de Pharmaceutical Research & Manufacturers of America, Karuna Therapeutics, Inc. et Generation Bio Co. Il a précédemment occupé les postes de président du conseil d'administration, président et directeur général d'Evogen, Inc, président, directeur général et directeur d'AVAX Technologies, Inc, vice-président de la recherche et du développement clinique d'Upjohn Laboratories LLC, vice-président exécutif d'Ionis Pharmaceuticals, Inc, président de Shire Regenerative Medicine, Inc, directeur médical et vice-président exécutif de Forest Laboratories, Inc, président de la division de médecine régénérative de Shire Plc, résident en chef du McLean Hospital, Inc et résident en chef de la Harvard Medical School. Il a obtenu un diplôme de premier cycle à l'Amherst College et un doctorat à la Harvard Medical School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
COMPASS PATHWAYS PLC -.--% | 27/05/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Jeff Jonas
| Sociétés | Poste | Début |
|---|---|---|
| COMPASS PATHWAYS PLC | Directeur/Membre du Conseil | 29/10/2025 |
Ryne Biotechnology, Inc.
 Ryne Biotechnology, Inc. BiotechnologyHealth Technology Operates as a biotechnology company for neuron replacement therapies for neurological conditions | Président | 01/02/2024 |
Cure Ventures Management LP
 Cure Ventures Management LP Investment ManagersFinance Cure Ventures invests in companies located in the United States. The firm targets companies operating in the fields of life science and biotechnology sectors. It provides financing for seed and early stage capital requirements. It acts as a lead investor and also makes follow-on investments. | Private Equity Investor | 01/01/2024 |
Angiocrine Bioscience, Inc.
 Angiocrine Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage cell and gene therapy company | Directeur/Membre du Conseil | - |
Noema Pharma AG
 Noema Pharma AG Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biotech company that provide therapeutics for central nervous system | Président | 04/10/2021 |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Directeur/Membre du Conseil | - |
Anciens postes connus de Jeff Jonas
| Sociétés | Poste | Fin |
|---|---|---|
| GENERATION BIO CO. | Directeur/Membre du Conseil | 06/02/2026 |
| SAGE THERAPEUTICS, INC. | Directeur Général | 15/12/2020 |
| KARA THER | Directeur/Membre du Conseil | 18/03/2024 |
| ░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Jeff Jonas
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
55
Relations au 1er degré
24
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 24 |
|---|---|
Forest Laboratories, Inc.
 Forest Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells drug products | Health Technology |
Ionis Pharmaceuticals, Inc.
 Ionis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops antisense drugs | Health Technology |
AVAX Technologies, Inc.
 AVAX Technologies, Inc. BiotechnologyHealth Technology Operates as development stage company with interest in the development and future commercialization of individualized cancer vaccines | Health Technology |
Shire Plc /Old/
 Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Develops, manufactures and markets pharmaceuticals | Commercial Services |
Shire Regenerative Medicine, Inc.
 Shire Regenerative Medicine, Inc. BiotechnologyHealth Technology Manufactures biomedical products | Health Technology |
CARA Therapeutics, Inc.
 CARA Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes new chemical entities designed to fundamentally change the way acute pain, chronic pain and pruritus are managed | Health Technology |
Angiocrine Bioscience, Inc.
Angiocrine Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage cell and gene therapy company | Commercial Services |
Amherst College
 Amherst College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
McLean Hospital, Inc.
 McLean Hospital, Inc. Hospital/Nursing ManagementHealth Services Provides healthcare services | Health Services |
Evogen, Inc.
 Evogen, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops technology for biological and chemical defense systems | Electronic Technology |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Upjohn Laboratories LLC | |
Swedish Orphan Biovitrum AB
 Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
Karuna Therapeutics, Inc.
 Karuna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops medicines for psychiatric and neurological disorders like schizophrenia and Alzheimer’s disease | Health Technology |
SAGE Therapeutics, Inc.
 SAGE Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel medicines for central nervous system disorders | Health Technology |
PureTech Health Plc
 PureTech Health Plc BiotechnologyHealth Technology Engages in the development of treatment programs for obesity, cognitive disorders, baldness, depression, allergy and autoimmune | Health Technology |
Decibel Therapeutics, Inc.
 Decibel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops medicines for hearing and balance disorders | Health Technology |
Generation Bio Co.
 Generation Bio Co. Pharmaceuticals: MajorHealth Technology Develops and commercializes genetic medicines | Health Technology |
Compass Pathways Plc
 Compass Pathways Plc BiotechnologyHealth Technology Develops therapies and drugs for the treatment of mental health and neurocognitive conditions | Health Technology |
Cure Ventures Management LP
Cure Ventures Management LP Investment ManagersFinance Cure Ventures invests in companies located in the United States. The firm targets companies operating in the fields of life science and biotechnology sectors. It provides financing for seed and early stage capital requirements. It acts as a lead investor and also makes follow-on investments. | Finance |
Noema Pharma AG
Noema Pharma AG Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biotech company that provide therapeutics for central nervous system | Commercial Services |
Ryne Biotechnology, Inc.
Ryne Biotechnology, Inc. BiotechnologyHealth Technology Operates as a biotechnology company for neuron replacement therapies for neurological conditions | Health Technology |
Abio-X Holdings, Inc. |
